Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by Boomskidon Jan 14, 2023 10:22am
112 Views
Post# 35223088

RE:RE:RE:Could The Ellipses Leak Force a Plan B?

RE:RE:RE:Could The Ellipses Leak Force a Plan B?Poof, you gotta be kidding us. That's not the question. The question is whether Rathjen and the BoD have held deals back that would have saved Bioasis from this sellout.

I didn't leak the Ellioses deal. Rathjen did. It looks to me like she had a deal and was going to use it to pitch Bioasis to Midatech, all under the the watchful and excited gaze of LT and The Placee. 

The trouble is, xB3-001 doesn't need Midatech. I doubt that Midatech/Biodexa can do anything with xB3-001 without further dilution. Midatech/Biodexa wilk likely do a deal like Bioasis could have done where a partner for xB3-001 or a buyer of xB3-001 could do the clinical work and foot the bill for it. 

The timing of the leak, Rathjen's presence in North America and the first meeting between Bioasis and Midatech together create a strong suspicion that Bioasis had a deal but was holding it back to get this lopsided sellout done.

If that is the case, how much more business has been postponed until LT and The Placee get control of Biodexa?

And if business has been postponed, which the entire BoD may or may not have known about, how much has been postponed until LT and The Placee get control of Biodexa?

Have Rathjen and Saltarelli delayed business deals for their own benefit at the expense of Bioasis shareholders? I contend that there is enough evidence of that to warrant some questions by regulators. Have deals been delayed, postponed, waved off or discouraged in favour of Midatech/Biodexa, Rathjen, Saltarelli, and LT and The Placee? 

It's all very simple, poof. It has nothing at all to do with what Midatech/Biodexa can or can't do. In the end they also will be under the control of LT and The Placee. Are Rathjen and Saltarelli, once on the BoD of Biodexa, going to be representing the interests of LT and The Placee? So far, it looks like their efforts are benefitting LT and The Placee and themselves far more than they are for anybody else. 

Call in the stock fuzz! 

jd


<< Previous
Bullboard Posts
Next >>